Vaccines in Australia's national programme are considered "very safe"
- PDF / 170,438 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 84 Downloads / 160 Views
1
Vaccines in Australia’s national programme are considered "very safe" Vaccines against serious diseases that are delivered as part of Australia’s National Immunisation Program "are very safe", according to the 2019 summary report of AusVaxSafety. AusVaxSafety is Australia’s national system for monitoring vaccine safety; the system is led by the National Centre for Immunisation Research and Surveillance, and it is funded by the Australian Government Department of Health. AusVaxSafety monitors vaccine safety via two primary means: (i) SMS responses and surveys from vaccine recipients, or their parents and carers, using SmartVax or Vaxtracker software; and (ii) data from specialist immunisation clinics obtained via the Adverse Events Following Immunisation – Clinical Assessment Network (AEFICAN). AusVaxSafety sends regular reports on vaccine safety to the Australian Government Department of Health, the Therapeutic Goods Administration, and other key stakeholders. Children receive vaccines through the National Immunisation Program at specific key ages (known as schedule points) – 2, 4, 6, 12 and 18 months, and 4 years. Adolescents, pregnant women, older people and other high-risk groups can also receive vaccines via this programme. Most of the adverse events post-vaccination were considered mild and resolved within a few days, and no safety issues were identified for any vaccines monitored under AusVaxSafety. Some of the important highlights of the 2019 report included the following: • a meningococcal vaccine (against types A, C, W and Y) was added to the National Immunisation Program in April 2019 for adolescents aged 14 to
Data Loading...
